
Sign up to save your podcasts
Or
Dr. David Boyer joins the podcast to discuss the Lumithera Valeda (photobiomodulation) FDA approval and what it means for retina specialists and patients.
Relevant Financial Disclosures: Dr. Boyer received research funding as a clinical trial site for Lumithera.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi
4.9
9797 ratings
Dr. David Boyer joins the podcast to discuss the Lumithera Valeda (photobiomodulation) FDA approval and what it means for retina specialists and patients.
Relevant Financial Disclosures: Dr. Boyer received research funding as a clinical trial site for Lumithera.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi
41 Listeners
16 Listeners
2,410 Listeners
5 Listeners
11 Listeners
570 Listeners
275 Listeners
11 Listeners
21 Listeners
48 Listeners
10 Listeners
1 Listeners
17 Listeners
17 Listeners
0 Listeners